Showing results (31-40 of 40) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Bioorganic Chemistry|June 30, 2020
Design, synthesis and anticonvulsant activity of new imidazolidindione and imidazole derivativesAdel A Marzouk, Amr K A Bass, Montaser Sh Ahmed, et al.RSC Advances|May 6, 2022
In silico identification of SARS-CoV-2 spike (S) protein-ACE2 complex inhibitors from eight Tecoma species and cultivars analyzed by LC-MSSeham S El Hawary, Amira R Khattab, Hanan S Marzouk, et al.Toxicology Mechanisms and Methods|October 18, 2022
Potential of paracetamol for reproductive disruption: molecular interaction, dynamics, and MM-PBSA based in-silico assessmentSayed Aliul Hasan Abdi, Abuzer Ali, Shabihul Fatma Sayed, et al.Cell Biochemistry and Biophysics|September 2, 2023
Investigation of Simultaneous and Sequential Cooperative Homotropic Inhibitor Binding to the Catalytic Chamber of SARS-CoV-2 RNA-dependent RNA Polymerase (RdRp)Kamel Metwally, Nader E Abo-Dya, Ahmed M E Hamdan, et al.Metabolites|December 23, 2021
Chemical Composition of the Red Sea Green Algae Ulva lactuca: Isolation and In Silico Studies of New Anti-COVID-19 CeramidesEnas E Eltamany, Sameh S Elhady, Marwa S Goda, et al.RSC Advances|May 6, 2022
Inhibition of SARS-CoV-2 main protease by phenolic compounds from Manilkara hexandra (Roxb.) Dubard assisted by metabolite profiling and in silico virtual screeningFatma M Abd El-Mordy, Mohamed M El-Hamouly, Magda T Ibrahim, et al.Molecules (Basel, Switzerland)|July 14, 2023
Combination of an Oxindole Derivative with (-)-β-Elemene Alters Cell Death Pathways in FLT3/ITD+ Acute Myeloid Leukemia CellsJowaher Alanazi, Onur Bender, Rumeysa Dogan, et al.Pharmaceuticals (Basel, Switzerland)|May 25, 2024
Discovery and Anticancer Screening of Novel Oxindole-Based Derivative Bearing Pyridyl Group as Potent and Selective Dual FLT3/CDK2 Kinase InhibitorAya Soudi, Onur Bender, Ismail Celik, et al.Molecular Cancer Biology|December 9, 2014
Computational and synthetic studies towards improving rescinnamine as an inducer of MSH2-dependent apoptosis in cancer treatmentElShimaa M N AbdelHafez, Andrew Diamanduros, Lacramioara Negureanu, et al.Archiv Der Pharmazie|November 20, 2022
Discovery of oxindole-based FLT3 inhibitors as a promising therapeutic lead for acute myeloid leukemia carrying the oncogenic ITD mutationOnur Bender, Mai E Shoman, Taha F S Ali, et al.Pageof 4